Behçet Syndrome 2019
DOI: 10.1007/978-3-030-24131-5_9
|View full text |Cite
|
Sign up to set email alerts
|

Behçet Syndrome: Gastrointestinal Involvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0
5

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 167 publications
0
3
0
5
Order By: Relevance
“…15 The main goal of treatment in patients with intestinal BD is to induce and maintain remission in order to minimize disease recurrence, surgical intervention, and the risk of irreversible bowel damage. 17 In the absence of a standard treatment, intestinal BD has been treated with corticosteroids or non-biologic immunomodulators; 18,19 however, many patients experience disease relapse following medical treatment with such agents, with results from a retrospective review in 93 patients with BD reporting cumulative recurrence rates of 24.9% at 2 years and 43.0% at 5 years, despite an initial high remission rate (66.7%). 20 Moreover, despite their widespread use, there remains a lack of evidence from prospective studies supporting the clinical efficacy of corticosteroids in intestinal BD, 21 with only a limited number of case reports demonstrating beneficial effects.…”
Section: Introductionmentioning
confidence: 99%
“…15 The main goal of treatment in patients with intestinal BD is to induce and maintain remission in order to minimize disease recurrence, surgical intervention, and the risk of irreversible bowel damage. 17 In the absence of a standard treatment, intestinal BD has been treated with corticosteroids or non-biologic immunomodulators; 18,19 however, many patients experience disease relapse following medical treatment with such agents, with results from a retrospective review in 93 patients with BD reporting cumulative recurrence rates of 24.9% at 2 years and 43.0% at 5 years, despite an initial high remission rate (66.7%). 20 Moreover, despite their widespread use, there remains a lack of evidence from prospective studies supporting the clinical efficacy of corticosteroids in intestinal BD, 21 with only a limited number of case reports demonstrating beneficial effects.…”
Section: Introductionmentioning
confidence: 99%
“…It shares several overlapping intestinal and extraintestinal manifestations with Crohn’s disease 2. Symptoms of intestinal BD include abdominal pain, haematochezia and weight loss 3. Oral ulcers usually precede the onset of GI symptoms 3.…”
Section: Answermentioning
confidence: 99%
“…Symptoms of intestinal BD include abdominal pain, haematochezia and weight loss 3. Oral ulcers usually precede the onset of GI symptoms 3. Altered bowel habit is less common in intestinal BD.…”
Section: Answermentioning
confidence: 99%
“…Y, para colmo, se han reportado casos de tuberculosis intestinal como complicación de la terapia biológica para EB, siendo entonces un diferencial a tener en cuenta tanto al momento del diagnóstico como en el seguimiento (33) . Dentro de las ayudas para diferenciar ambas entidades están la ausencia de compromiso extra intestinal en TB, la presencia de TB diseminada o pulmonar en el 50% de los casos, la presencia de fiebre (aunque no excluye EB debe hacer pensar como primera opción en TB) (6,34) . Desde el punto de vista endoscópico la TB se presenta con úlceras únicas o múltiples circunferenciales, en pocas localizaciones, o en estadios tardíos la TB se presenta como nódulos hipertrofiados de distribución circunferencial (34) .…”
Section: Diagnóstico Diferencialunclassified
“…Es importante hacer búsqueda de estenosis cercanas a la válvula ileocecal, adenopatías con centro necrótico en la tomografía de abdomen o calcificaciones que favorecen la Tb como diagnóstico. Finalmente, el diferencial entre ambas se hará basados en la histología, el cultivo y los métodos de biología molecular, donde la presencia de necrosis incluso sin caseificación dará como primera opción diagnostica la tuberculosis (en el contexto clínico adecuado), además de la PCR positiva para TB o un cultivo positivo (34) .…”
Section: Diagnóstico Diferencialunclassified